Evidence map›Paper›PMID 31300558›Full record

ArticleRNA (New York, N.Y.)2019

DOT1L complex suppresses transcription from enhancer elements and ectopic RNAi in

Ruben Esse, Ekaterina S Gushchanskaia, Avery Lord, Alla Grishok

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. DOT-1.1 (DOT1L) deficiency inBBA advances · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Cells · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ruben EsseDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Ekaterina S GushchanskaiaDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Avery LordDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Alla GrishokDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Boston University · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Regulation of RNA processing and transcription by endogenous RNAiR01GM107056 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GRISHOK, ALLA · 2014 to 2017
$1.2M
NCATS NIH HHS UL1 TR001430NIGMS NIH HHS R01 GM107056NIH HHS P40 OD010440
6 · The paper itself

Abstract

Methylation of histone H3 on lysine 79 (H3K79) by DOT1L is associated with actively transcribed genes. Earlier, we described that DOT-1.1, the

Indexed as

Enhancer Elements, GeneticRNA InterferenceAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsDNA MethylationHistone-Lysine N-MethyltransferaseNeuronsProtein BindingTranscription FactorsTranscription, GeneticCaenorhabditis elegans ProteinsHistone-Lysine N-MethyltransferaseTranscription FactorsZfp-1 protein, C elegansantisense RNADOT1LenhancersH3K79RNA interferenceZFP-1/AF10

Identifiers

PMID31300558
PMCPMC6800474
OpenAlexW2956696927

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.